Zymenex Report issue

For profit Phase 2 Phase 3
Founded: Hillerod Denmark (1998)
Status: Acquired by Chiesi (2013)

Organization Overview

First Clinical Trial
2003
NCT00418795
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Zymenex A/S